OLZ alleviated dopamine D2 receptor priming and cognitive impairment and reduced neurotrophins and acetylcholinergic markers produced by D2 receptor priming in the hippocampus (Thacker et al., 2006). This evidence concerns the gene BDNF and Cognitive impairment.